ICU

Michael Messinger

Known title: Chief Financial OfficerCIK: 0001615039

Michael Messinger's purchase track record

Michael Messinger has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.

PurchaseStockAmount3 months6 months
8/18/2026ICU$2Kpendingpending
12/9/2025ICU$5K-24.4%-21.9%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 2, 2026

SeaStar Medical Adds ICD‑10‑PCS Codes for AKI Therapy. SeaStar Medical has released new ICD‑10‑PCS codes for its SCD therapy used in acute kidney injury. The codes allow hospitals to bill for the treatment, which could broaden usage. Earlier this week the company’s Chief Medical Officer, Kevin Chung, will speak at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium, highlighting the therapy’s pediatric applications. The company’s shares are trading near a key support level and have shown a recent volume spike.

this person other insiders at ICU

Transaction History

ICU▲ Buy$2K
ICU▲ Buy$5K

We use analytics to understand how market-wall is used. No personal data is sold.